Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting

BACKGROUND: Dabigatran etexilate may be underutilized in geriatric patients because of inadequate clinical experience in individuals with severe renal impairment and post-marketing reports of bleeding events. Assessing the degree of anticoagulation may improve the risk:benefit ratio for dabigatran....

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Luigi, Sanchez-Catanese, Betty, Kagan, Leonid, Wen, Xia, Liu, Min, Buckley, Brian, Luyendyk, James P., Aleksunes, Lauren M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858862/
https://www.ncbi.nlm.nih.gov/pubmed/27158246
http://dx.doi.org/10.1186/s12959-016-0084-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858862/
https://www.ncbi.nlm.nih.gov/pubmed/27158246
http://dx.doi.org/10.1186/s12959-016-0084-2

Ejemplares similares